Bill Sponsors: US HB7174 | 2023-2024 | 118th Congress

Bill Title: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Spectrum: Moderate Partisan Bill (Republican 8-1)

Status: (Introduced) 2024-01-31 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. [HB7174 Detail]

Text: Latest bill text (Introduced) [PDF]

Sponsors

NameTypeSponsorshipDistrictFinancialFinancialEncyclopediaBiographyBioGuide
Representative Greg Murphy [R]PrimarySponsored BillsHD-NC-3OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
Representative Donald Davis [D]CosponsorSponsored BillsHD-NC-1N/AN/ABallotpediaVoteSmartBioGuide
Representative Brett Guthrie [R]CosponsorSponsored BillsHD-KY-2OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
Representative Carol Miller [R]CosponsorSponsored BillsHD-WV-1OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
Representative John Curtis [R]CosponsorSponsored BillsHD-UT-3OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
Representative Brad Wenstrup [R]CosponsorSponsored BillsHD-OH-2OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
Representative Rudolph Yakym III [R]CosponsorSponsored BillsHD-IN-2N/AN/ABallotpediaVoteSmartBioGuide
Representative Nicole Malliotakis [R]CosponsorSponsored BillsHD-NY-11OpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
Representative Thomas Kean [R]CosponsorSponsored BillsHD-NJ-7N/AN/ABallotpediaVoteSmartBioGuide

Social Comments on US HB7174

feedback